Type 2 Diabetes Trial, Recruiting (NCT03549754)

Type 2 Diabetes Trial, Recruiting NCT03549754 Sponsor: AstraZeneca Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT03549754 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with at least one of the following conditions: type 2 diabetes, high blood pressure, heart failure, or chronic kidney disease
People who are willing and able to sign a written consent form to participate in the registry

Who may not be able to join:

People who have a serious life-threatening illness where life expectancy is less than one year
People who are currently taking part in another clinical trial that required them to sign a separate consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hardik Vasnawala, MD, AstraZeneca

Phone: 1-877-240-9479

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03549754

Sponsor: AstraZeneca

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 1-877-240-9479

More information: https://clinicaltrials.gov/study/NCT03549754

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with at least one of the following conditions: type 2 diabetes, high blood pressure, heart failure, or chronic kidney disease
People who are willing and able to sign a written consent form to participate in the registry

Who may not be able to join:

People who have a serious life-threatening illness where life expectancy is less than one year
People who are currently taking part in another clinical trial that required them to sign a separate consent form

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

AstraZeneca

Registry

ClinicalTrials.gov

Start date

17 February 2018

Est. completion

31 December 2030

Where this trial is recruiting

🇧🇷 Brazil 🇨🇱 Chile Costa Rica Côte d’Ivoire 🇪🇬 Egypt 🇬🇪 Georgia Ghana Hong Kong 🇮🇳 India Iraq 🇰🇿 Kazakhstan Kenya 🇲🇾 Malaysia 🇲🇽 Mexico Nigeria 🇵🇭 Philippines 🇿🇦 South Africa 🇹🇼 Taiwan 🇺🇦 Ukraine 🇦🇪 United Arab Emirates

Primary endpoints

1. Age of particpants; 2. Percentage of Participants by Sex; 3. Percentage of Participants by Ethnicity; 4. Percentage of Participants by Education Level; 5. Percentage of Participants by Marital Status; 6. Percentage of Participants with Family History of Cardiovascular and Renal-Metabolic Disease; 7.Percentage of Participants by Physical Activity Level; 8. Percentage of Participants by Smoking Status; 9. Percentage of Participants by Alcohol Consumption; 10. Body Weight of Participants; 11. Height of Participants; 12. Body Mass Index (BMI) of Participants; 13. Waist Circumference of Particip...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov